Search research articles
Contact Us
Filters
Showing results (71-80 of 202) with videos related to
Page
of 21
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 20, 2015
Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease
J W Jukema, M Lenselink, G J de Grooth, et al.
Annals of Human Genetics
|
April 5, 2003
Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein gene locus
M W T Tanck, A H E M Klerkx, J W Jukema, et al.
The American Journal of Cardiology
|
October 6, 2000
Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)
H J Mulder, E T Bal, J W Jukema, et al.
European Journal of Clinical Investigation
|
February 27, 2004
Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)
A H E M Klerkx, G J de Grooth, A H Zwinderman, et al.
Peptides
|
October 15, 2020
Interplay of circulating leptin and obesity in cognition and cerebral volumes in older adults
M H Zonneveld, R Noordam, J van der Grond, et al.
European Journal of Preventive Cardiology
|
November 26, 2015
Advantages and disadvantages of unstructured cardiovascular risk factor screening for follow-up in primary care
Anna W de Boer, Renée de Mutsert, Martin den Heijer, et al.
Fortschritte Der Medizin
|
March 20, 1996
[Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program]
R P Byington, J W Jukema, J T Salonen, et al.
The New England Journal of Medicine
|
January 8, 1998
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group
J A Kuivenhoven, J W Jukema, A H Zwinderman, et al.
International Journal of Cardiology
|
July 11, 2006
Assessment of left ventricular volumes and ejection fraction with 16-slice multi-slice computed tomography; comparison with 2D-echocardiography
J D Schuijf, J J Bax, J W Jukema, et al.
International Journal of Cardiology
|
September 10, 2018
Borderline Q-waves in individuals without overt cardiovascular disease: Relations with adiposity, subclinical atherosclerosis and vascular stiffness
T W Elffers, S Trompet, R de Mutsert, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 202) with videos related to
Sort By:
Page
of 21
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 20, 2015
Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease
J W Jukema, M Lenselink, G J de Grooth, et al.
Annals of Human Genetics
|
April 5, 2003
Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein gene locus
M W T Tanck, A H E M Klerkx, J W Jukema, et al.
The American Journal of Cardiology
|
October 6, 2000
Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)
H J Mulder, E T Bal, J W Jukema, et al.
European Journal of Clinical Investigation
|
February 27, 2004
Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)
A H E M Klerkx, G J de Grooth, A H Zwinderman, et al.
Peptides
|
October 15, 2020
Interplay of circulating leptin and obesity in cognition and cerebral volumes in older adults
M H Zonneveld, R Noordam, J van der Grond, et al.
European Journal of Preventive Cardiology
|
November 26, 2015
Advantages and disadvantages of unstructured cardiovascular risk factor screening for follow-up in primary care
Anna W de Boer, Renée de Mutsert, Martin den Heijer, et al.
Fortschritte Der Medizin
|
March 20, 1996
[Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program]
R P Byington, J W Jukema, J T Salonen, et al.
The New England Journal of Medicine
|
January 8, 1998
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group
J A Kuivenhoven, J W Jukema, A H Zwinderman, et al.
International Journal of Cardiology
|
July 11, 2006
Assessment of left ventricular volumes and ejection fraction with 16-slice multi-slice computed tomography; comparison with 2D-echocardiography
J D Schuijf, J J Bax, J W Jukema, et al.
International Journal of Cardiology
|
September 10, 2018
Borderline Q-waves in individuals without overt cardiovascular disease: Relations with adiposity, subclinical atherosclerosis and vascular stiffness
T W Elffers, S Trompet, R de Mutsert, et al.
Page
of 21